Study on the effects of sitagliptin on glycemic control in newly treated or uncontrolled patients with type 2 diabetes mellitus - Study on the effects of sitagliptin on glycemic control in newly treated or uncontrolled patients with type 2 diabetes mellitus (JAMP study)

Kanto Antidiabetics Study Group0 个研究点目标入组 1,400 人开始时间: 2015年10月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients who met any of the following criteria are to be excluded: 1) Patients with a history of severe ketosis, diabetic coma or pre-coma within the past 6 months 2) Patients who are about to have or who have undergone an operation or who have severe infections or serious injury 3) Pregnant, possibly pregnant, or lactating women 4) Patients with moderate kidney dysfunction (serum creatinine >or= 1.5 mg/dL for men, >or= 1.3 mg/dL for women ) 5) Patients who are being treated with insulin 6) Patients who are being treated with rapid acting insulin secretagogues 7) Patients with a history of hypersensitivity to ingredients of the study drug 8) Patients who are considered not eligible for the study by the attending doctor due to medical reasons

发起方

Kanto Antidiabetics Study Group